1267 related articles for article (PubMed ID: 25762559)
21. Everolimus-eluting stent implantation versus repeat paclitaxel-coated balloon angioplasty for recurrent in-stent restenosis lesion caused by paclitaxel-coated balloon failure.
Kubo S; Kadota K; Otsuru S; Hasegawa D; Habara S; Tada T; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
EuroIntervention; 2015 Jan; 10(9):e1-8. PubMed ID: 25599699
[TBL] [Abstract][Full Text] [Related]
22. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T
Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360
[TBL] [Abstract][Full Text] [Related]
23. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
[TBL] [Abstract][Full Text] [Related]
24. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
[TBL] [Abstract][Full Text] [Related]
25. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
Almalla M; Schröder J; Pross V; Marx N; Hoffmann R
Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557
[TBL] [Abstract][Full Text] [Related]
27. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
30. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
31. Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.
Nagoshi R; Shinke T; Otake H; Shite J; Matsumoto D; Kawamori H; Nakagawa M; Kozuki A; Hariki H; Inoue T; Ohsue T; Taniguchi Y; Iwasaki M; Nishio R; Hiranuma N; Konishi A; Kinutani H; Miyoshi N; Takaya T; Yamada S; Yasaka Y; Hayashi T; Yokoyama M; Kato H; Kadotani M; Ohnishi Y; Hirata K
Circ J; 2013; 77(3):652-60. PubMed ID: 23257388
[TBL] [Abstract][Full Text] [Related]
32. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon.
Ali RM; Abdul Kader MASK; Wan Ahmad WA; Ong TK; Liew HB; Omar AF; Mahmood Zuhdi AS; Nuruddin AA; Schnorr B; Scheller B
JACC Cardiovasc Interv; 2019 Mar; 12(6):558-566. PubMed ID: 30898253
[TBL] [Abstract][Full Text] [Related]
34. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
[TBL] [Abstract][Full Text] [Related]
35. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
Giacoppo D; Alvarez-Covarrubias HA; Koch T; Cassese S; Xhepa E; Kessler T; Wiebe J; Joner M; Hochholzer W; Laugwitz KL; Schunkert H; Kastrati A; Kufner S
Eur Heart J; 2023 Apr; 44(15):1343-1357. PubMed ID: 36807512
[TBL] [Abstract][Full Text] [Related]
36. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
[TBL] [Abstract][Full Text] [Related]
37. Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
Miura K; Kadota K; Habara S; Shimada T; Ohya M; Amano H; Kubo S; Hyodo Y; Otsuru S; Tada T; Tanaka H; Fuku Y; Goto T
Am J Cardiol; 2017 Feb; 119(3):365-371. PubMed ID: 27894569
[TBL] [Abstract][Full Text] [Related]
38. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
[TBL] [Abstract][Full Text] [Related]
39. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
[TBL] [Abstract][Full Text] [Related]
40. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
Solinas E; Dangas G; Kirtane AJ; Lansky AJ; Franklin-Bond T; Boland P; Syros G; Kim YH; Gupta A; Mintz G; Fahy M; Collins M; Kodali S; Stone GW; Moses JW; Leon MB; Mehran R
Am J Cardiol; 2008 Aug; 102(3):311-5. PubMed ID: 18638592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
